
To Educate Customers and Support Sales Growth in the California Region
ImmuCell Corporation is pleased to announce Jonathan Ocampo has joined its team as Sales and Marketing Manager to help the company keep pace with demand for First Defense® products across California, Arizona and Nevada. Ocampo will focus on helping dairy and beef producers, veterinarians, and distribution partners to better understand ImmuCell’s First Defense® product line and its role in supporting calf health. First Defense provides calves with immediate immunity against the most common scours-causing pathogens, including E. coli, coronavirus, and rotavirus. He will work to build strong relationships and support producers with practical solutions for protecting newborn calves.
Ocampo developed his on-farm expertise during his decade as a ranch manager. He also has ten years of outside sales experience across California’s dairy and livestock industries. Prior to joining ImmuCell, Ocampo was with Foster Farms, leading their large dairy commodity business throughout Central and Northern California.
“Jonathan brings a strong ability to build relationships in the field and connect with decision-makers on large dairy operations,” said Bobbi Brockmann, ImmuCell Senior Vice President of Sales and Marketing. “With his knowledge of calf health and First Defense products, he will be a valuable resource for producers looking to strengthen their newborn calf care programs. We’re excited to have his work ethic and determination supporting our customers and distribution partners.”
Ocampo is bilingual in English and Spanish. He earned his bachelor’s degree in animal sciences from California State University, Fresno.
ImmuCell Corporation (Nasdaq: ICCC) is an animal health biologics company serving the dairy and beef industries with practical, science-based solutions that improve the survivability, health, and long-term performance of dairy and beef calves. The Company’s primary product line, First Defense®, provides Immediate Immunity™ through orally delivered antibodies against the principal viral and bacterial causes of scours, one of the most prevalent and deadly diseases in neonatal calves worldwide. Press releases and other information about the Company are available at http://www.immucell.com.

Be the first to comment